Fluorescence guided resection and glioblastoma in 2015: A review
暂无分享,去创建一个
Maximilien Vermandel | Serge Mordon | Nicolas Reyns | Henri-Arthur Leroy | S. Mordon | N. Reyns | M. Vermandel | H. Leroy | J. Lejeune | Jean-Paul Lejeune
[1] A. E. Saarnak,et al. 5-Aminolevulinic Acid Induced Endogenous Porphyrin Fluorescence in 9L and C6 Brain Tumours and in the Normal Rat Brain , 1998, Acta Neurochirurgica.
[2] Kathleen Seidel,et al. Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brain mapping. , 2012, Neurosurgery.
[3] D. Kessel,et al. Plasma levels of protoporphyrin IX in humans after oral administration of 5-aminolevulinic acid. , 1997, Journal of photochemistry and photobiology. B, Biology.
[4] N. J. Brown,et al. The influence of hypoxia and pH on aminolaevulinic acid-induced photodynamic therapy in bladder cancer cells in vitro. , 1998, British Journal of Cancer.
[5] Giuseppe Lombardi,et al. 5-aminolevulinic acid (5-ALA) fluorescence guided surgery of high-grade gliomas in eloquent areas assisted by functional mapping. Our experience and review of the literature , 2013, Acta Neurochirurgica.
[6] Y. Kajimoto,et al. Endoscopic identification and biopsy sampling of an intraventricular malignant glioma using a 5-aminolevulinic acid-induced protoporphyrin IX fluorescence imaging system. Technical note. , 2007, Journal of neurosurgery.
[7] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[8] R. Mirimanoff,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[9] J. Olson,et al. Guidelines for the treatment of newly diagnosed glioblastoma: introduction , 2008, Journal of Neuro-Oncology.
[10] Isabelle Camby,et al. Present and potential future issues in glioblastoma treatment , 2006, Expert review of anticancer therapy.
[11] H. Steiger,et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of brain tumors in children—a technical report , 2014, Acta Neurochirurgica.
[12] Thomas Pongratz,et al. ALA and malignant glioma: fluorescence-guided resection and photodynamic treatment. , 2007, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.
[13] Francesco Acerbi,et al. Is fluorescein-guided technique able to help in resection of high-grade gliomas? , 2014, Neurosurgical focus.
[14] Walter Stummer,et al. Favorable outcome in the elderly cohort treated by concomitant temozolomide radiochemotherapy in a multicentric phase II safety study of 5-ALA , 2011, Journal of Neuro-Oncology.
[15] M. Idoate,et al. Pathological characterization of the glioblastoma border as shown during surgery using 5‐aminolevulinic acid‐induced fluorescence , 2011, Neuropathology : official journal of the Japanese Society of Neuropathology.
[16] D. Barone,et al. Image guided surgery for the resection of brain tumours. , 2014, The Cochrane database of systematic reviews.
[17] Henry Brem,et al. Independent association of extent of resection with survival in patients with malignant brain astrocytoma. , 2009, Journal of neurosurgery.
[18] Gabriele Schackert,et al. Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. , 2008, Neuro-oncology.
[19] J. Slof,et al. Observational, retrospective study of the effectiveness of 5-aminolevulinic acid in malignant glioma surgery in Spain (The VISIONA study) , 2014 .
[20] Jochen Herms,et al. 5‐Aminolevulinic Acid‐induced Protoporphyrin IX Levels in Tissue of Human Malignant Brain Tumors , 2010, Photochemistry and photobiology.
[21] G von Campe,et al. 5-aminolevulinic acid induced protoporphyrin IX fluorescence in high-grade glioma surgery: a one-year experience at a single institutuion. , 2008, Swiss medical weekly.
[22] Sachio Suzuki,et al. Fluorescence-guided resection of metastatic brain tumors using a 5-aminolevulinic acid-induced protoporphyrin IX: pathological study , 2007, Brain Tumor Pathology.
[23] J. Henson,et al. Brain Tumor Imaging in Clinical Trials , 2008, American Journal of Neuroradiology.
[24] S. Preston‐Martin,et al. A population‐based description of glioblastoma multiforme in Los Angeles County, 1974–1999 , 2005, Cancer.
[25] H. Steiger,et al. Enhancing the effect of 5-aminolevulinic acid based photodynamic therapy in human meningioma cells. , 2014, Photodiagnosis and photodynamic therapy.
[26] A. Ehrhardt,et al. Use of 5-ALA fluorescence guided endoscopic biopsy of a deep-seated primary malignant brain tumor. , 2011, Journal of Neurosurgery.
[27] Mamta Khurana,et al. Quantification of in vivo fluorescence decoupled from the effects of tissue optical properties using fiber-optic spectroscopy measurements. , 2010, Journal of biomedical optics.
[28] J. Zo,et al. Reduced local recurrence of a single brain metastasis through microscopic total resection. , 2009, Journal of neurosurgery.
[29] M. Matsumae,et al. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma. , 2011, World neurosurgery.
[30] N. J. Brown,et al. Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett’s esophagus , 2004, Surgical Endoscopy And Other Interventional Techniques.
[31] Xiaoyao Fan,et al. Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. , 2011, Journal of neurosurgery.
[32] N. Brown,et al. Aminolaevulinic acid-induced photodynamic therapy: cellular responses to glucose starvation , 2002, British Journal of Cancer.
[33] R. Keep,et al. Role of PEPT2 in the Choroid Plexus Uptake of Glycylsarcosine and 5-Aminolevulinic Acid: Studies in Wild-Type and Null Mice , 2004, Pharmaceutical Research.
[34] J. Jääskeläinen,et al. Debulking or biopsy of malignant glioma in elderly people – a randomised study , 2003, Acta Neurochirurgica.
[35] Walter Stummer,et al. The importance of surgical resection in malignant glioma , 2009, Current opinion in neurology.
[36] L. Morgan,et al. The epidemiology of glioma in adults: a "state of the science" review. , 2015, Neuro-oncology.
[37] F. Zanella,et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.
[38] D. Prayer,et al. 5‐Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement , 2010, Cancer.
[39] H. Steiger,et al. Endoscopic-assisted visualization of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery: a technical note. , 2014, World neurosurgery.
[40] B. Kleinschmidt-DeMasters,et al. Clinical and molecular characteristics of congenital glioblastoma. , 2012, Neuro-oncology.
[41] A. Omuro,et al. Current Role of Anti-Angiogenic Strategies for Glioblastoma , 2014, Current Treatment Options in Oncology.
[42] J. Slof,et al. Observational, retrospective study of the effectiveness of 5-aminolevulinic acid in malignant glioma surgery in Spain (The VISIONA study). , 2014, Neurologia.
[43] M. Ritsch-Marte,et al. mTHPC-mediated Photodynamic Diagnosis of Malignant Brain Tumors¶ , 2001, Photochemistry and photobiology.
[44] J. Meixensberger,et al. The use of 5-aminolevulinic acid fluorescence guidance in resection of pediatric brain tumors , 2013, Child's Nervous System.
[45] J. Slof,et al. Análisis coste-efectividad de la cirugía del glioma maligno guiada por fluorescencia con ácido 5-aminolevulínico , 2015 .
[46] P. Cabre,et al. A case of late-onset multiple sclerosis mimicking glioblastoma and displaying intraoperative 5-aminolevulinic acid fluorescence , 2012, Acta Neurochirurgica.
[47] J. Honegger,et al. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[48] Sachio Suzuki,et al. Histological examination of false positive tissue resection using 5-aminolevulinic acid-induced fluorescence guidance. , 2007, Neurologia medico-chirurgica.
[49] Kevin Petrecca,et al. Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma , 2012, Journal of Neuro-Oncology.
[50] R. Díez-Valle,et al. Prognostic value of ventricular wall fluorescence during 5-aminolevulinic-guided surgery for glioblastoma , 2012, Acta Neurochirurgica.
[51] J. Slof,et al. Cost-effectiveness of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery. , 2015, Neurologia.
[52] Veit Rohde,et al. EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME: IDENTIFICATION OF AND ADJUSTMENT FOR BIAS , 2008, Neurosurgery.
[53] S. Eljamel. Photodynamic applications in brain tumors: a comprehensive review of the literature. , 2010, Photodiagnosis and photodynamic therapy.
[54] M. Eljamel,et al. Fluorescence image-guided surgery of brain tumors: explained step-by-step. , 2008, Photodiagnosis and photodynamic therapy.
[55] J Moan,et al. 5‐Aminolevulinic acid‐based photodynamic therapy , 1997, Cancer.
[56] H. Steiger,et al. The impact of improved treatment strategies on overall survival in glioblastoma patients , 2013, Acta Neurochirurgica.
[57] J. Barnholtz-Sloan,et al. The epidemiology of glioma in adults: a "state of the science" review. , 2014, Neuro-oncology.
[58] Neda Haj-Hosseini,et al. Optical touch pointer for fluorescence guided glioblastoma resection using 5‐aminolevulinic acid , 2010, Lasers in surgery and medicine.
[59] Frederic Leblond,et al. System and methods for wide-field quantitative fluorescence imaging during neurosurgery. , 2013, Optics letters.
[60] Katsushi Inoue,et al. Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy. , 2011, International immunopharmacology.
[61] I. Baldi,et al. [Epidemiology of glioblastoma]. , 2010, Neuro-Chirurgie.
[62] Giuseppe Lombardi,et al. 5-Aminolevulinic Acid Fluorescence in High Grade Glioma Surgery: Surgical Outcome, Intraoperative Findings, and Fluorescence Patterns , 2014, BioMed research international.
[63] F. Certo,et al. 5-ALA fluorescence-assisted surgery in pediatric brain tumors: Report of three cases and review of the literature , 2014, British journal of neurosurgery.
[64] A. Jemal,et al. Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.
[65] A. Obwegeser,et al. Uptake and kinetics of 14C-labelled meta-tetrahydroxyphenylchlorin and 5-aminolaevulinic acid in the C6 rat glioma model. , 1998, British Journal of Cancer.
[66] J. Slof,et al. Observational, retrospective study of the effectiveness of 5-aminolevulinic acid in malignant glioma surgery in Spain (The VISIONA study) , 2014 .
[67] T. Stephenson,et al. 5‐Aminolevulinic Acid Photosensitization of Dysplastic Barrett's Esophagus: A Pharmacokinetic Study , 1999, Photochemistry and photobiology.
[68] L. Deangelis,et al. Glioblastoma and other malignant gliomas: a clinical review. , 2013, JAMA.
[69] F. Floeth,et al. Finding the anaplastic focus in diffuse gliomas: The value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence , 2011, Clinical Neurology and Neurosurgery.
[70] Frederic Leblond,et al. 5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence in Meningioma: Qualitative and Quantitative Measurements In Vivo , 2014, Neurosurgery.
[71] Jian Chen,et al. Fluorescence-guided resection of high-grade gliomas: a systematic review and meta-analysis. , 2014, Photodiagnosis and photodynamic therapy.
[72] Mitchel S. Berger,et al. Current and future strategies for treatment of glioma , 2016, Neurosurgical Review.
[73] Q. Peng,et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. , 1997, Cancer.
[74] W. Stummer,et al. Technical Principles for Protoporphyrin-IX-Fluorescence Guided Microsurgical Resection of Malignant Glioma Tissue , 1998, Acta Neurochirurgica.
[75] S. Tejada Solis,et al. Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience , 2011, Journal of Neuro-Oncology.
[76] Maximilien Vermandel,et al. Experimental use of photodynamic therapy in high grade gliomas: a review focused on 5-aminolevulinic acid. , 2014, Photodiagnosis and photodynamic therapy.
[77] G. Reifenberger,et al. 5-Aminolevulinic acid (5-ALA)-induced fluorescence in intracerebral metastases: a retrospective study , 2012, Acta Neurochirurgica.
[78] M. Colditz,et al. Aminolevulinic acid (ALA)–protoporphyrin IX fluorescence guided tumour resection. Part 2: Theoretical, biochemical and practical aspects , 2012, Journal of Clinical Neuroscience.
[79] W. Stummer,et al. Transport of 5-aminolevulinic acid between blood and brain , 2003, Brain Research.
[80] J C Kennedy,et al. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. , 1992, Journal of photochemistry and photobiology. B, Biology.
[81] Rosalind L. Jeffree,et al. Aminolevulinic acid (ALA)–protoporphyrin IX fluorescence guided tumour resection. Part 1: Clinical, radiological and pathological studies , 2012, Journal of Clinical Neuroscience.
[82] Xiaofeng Chen,et al. Intraoperative Fluorescence-Guided Resection of High-Grade Malignant Gliomas Using 5-Aminolevulinic Acid–Induced Porphyrins: A Systematic Review and Meta-Analysis of Prospective Studies , 2013, PloS one.
[83] Alireza Gharabaghi,et al. Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring. , 2010, Journal of neurosurgery.
[84] D. Maucort-Boulch,et al. [Surgery of high-grade gliomas guided by fluorescence: a retrospective study of 22 patients]. , 2013, Neuro-Chirurgie.
[85] G. Iacob,et al. Current data and strategy in glioblastoma multiforme , 2009, Journal of medicine and life.
[86] N. Sanai,et al. Trends in fluorescence image-guided surgery for gliomas. , 2014, Neurosurgery.
[87] Jörg-Christian Tonn,et al. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article. , 2011, Journal of neurosurgery.
[88] Kaoru Sakatani,et al. Quantitative spectroscopic analysis of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence intensity in diffusely infiltrating astrocytomas. , 2007, Neurologia medico-chirurgica.
[89] J. Hamada,et al. Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy , 2011, British Journal of Cancer.
[90] V. Ntziachristos,et al. Optical innovations in surgery , 2015, The British journal of surgery.
[91] Mitchel S Berger,et al. An extent of resection threshold for newly diagnosed glioblastomas. , 2011, Journal of neurosurgery.
[92] R. Keep,et al. Peptide transporter 2 (PEPT2) expression in brain protects against 5‐aminolevulinic acid neurotoxicity , 2007, Journal of neurochemistry.
[93] Xiaoyao Fan,et al. Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article. , 2011, Journal of neurosurgery.
[94] Kathleen Seidel,et al. Early Re-Do Surgery for Glioblastoma Is a Feasible and Safe Strategy to Achieve Complete Resection of Enhancing Tumor , 2013, PloS one.
[95] T. Ishikawa,et al. Enhanced expression of coproporphyrinogen oxidase in malignant brain tumors: CPOX expression and 5-ALA-induced fluorescence. , 2011, Neuro-oncology.
[96] Jörg-Christian Tonn,et al. Fluorescence-guided resection of malignant gliomas using 5-aminolevulinic acid: practical use, risks, and pitfalls. , 2008, Clinical neurosurgery.
[97] Walter Stummer,et al. Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion , 2011, Acta Neurochirurgica.
[98] Z L Gokaslan,et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. , 2001, Journal of neurosurgery.
[99] J. Fandino,et al. Intraoperative 5-aminolevulinic-acid-induced fluorescence in meningiomas , 2010, Acta Neurochirurgica.